By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

UCB, Inc. 

1950 Lake Park Drive

Smyrna  Georgia  30080  U.S.A.
Phone: 770-437-5705 Fax: 770-437-5640


SEARCH JOBS




Collaborations

The Medicines Company  Contract manufacturing of Bivalirudin peptide active ingredient

Praecis Pharmaceuticals Incorporated  Contract manufacturing of Abarelix peptide active ingredient

Amgen  Contract manufacturing of Abarelix peptide active ingredient

Bausch & Lomb  Contract manufacturing of active pharmaceutical ingredient





Company News
Wilex AG (WL6.DE) Sends Back Some Promising Drugs To UCB, Inc. (UCBJF.PK) In Effort To Stay Alive 5/22/2014 7:36:33 AM
UCB, Inc. (UCBJF.PK) Announces Data From First Seven Year Evaluation Of Cimzia® (Certolizumab Pegol) In Moderate To Severe Crohn's Disease Patients 5/5/2014 8:54:03 AM
Sanofi (France) (SAN.PA), UCB, Inc. (UCBJF.PK) Strikes $138 Million Pact To Seek Anti-Inflammatory Small Molecules 3/11/2014 7:39:07 AM
UCB, Inc. (UCBJF.PK) CEO Out, Biopharma Chief Appointed To Top Post 2/20/2014 7:25:06 AM
UCB, Inc. (UCBJF.PK) And UK's MRC Technology Sign Exclusive License Agreement For A Fibrosis Program 2/13/2014 9:48:29 AM
Biogen, Inc. And UCB, Inc. (UCBJF.PK) Enter Agreements To Commercialize Multiple Sclerosis And Hemophilia Therapies In Asia 1/30/2014 11:56:57 AM
InteRNA Technologies, UCB, Inc. (UCBJF.PK) And University of Bonn To Collaborate On The Role Of MicroRNAs In Neurodegenerative Disease 1/10/2014 9:04:55 AM
Amgen (AMGN), UCB, Inc. (UCBJF.PK): Osteoporosis Phase 2 Drug Trial A Success 1/2/2014 6:35:53 AM
Oncodesign SA And UCB, Inc. (UCBJF.PK) Enter Into A Research Collaboration For The Early Development Of New Therapeutic Agents In Neurodegenerative Diseases 11/13/2013 9:06:53 AM
UCB, Inc. (UCBJF.PK) Files VIMPAT® (Lacosamide) in the U.S. as Monotherapy Treatment in Adult Epilepsy Patients With Partial-Onset Seizures 11/4/2013 9:39:58 AM
12345678910...
//-->